Texas 2021 - 87th Regular

Texas Senate Bill SR431 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 SENATE RESOLUTION NO. 431
22 WHEREAS, Cystic fibrosis, commonly referred to as CF, is a
33 genetic disease that affects approximately 30,000 children and
44 adults in the United States and nearly 70,000 children and adults
55 worldwide, more than 2,000 of whom live in this state; and
66 WHEREAS, In persons with cystic fibrosis, a defective gene
77 causes the body to produce an abnormally thick, sticky mucus that
88 clogs the lungs, and these secretions produce life-threatening
99 lung infections; the secretions also obstruct the pancreas and
1010 prevent its digestive enzymes from reaching the intestines to
1111 help the body break down and absorb food; and
1212 WHEREAS, More than 10 million Americans are symptomless
1313 carriers of the defective CF gene, and this disease occurs in
1414 approximately one of every 3,500 live births in the United
1515 States; the median predicted age of survival for a person with
1616 cystic fibrosis born in 2017 was 46.2 years; and
1717 WHEREAS, With advances in the treatment of CF, the number
1818 of adults living with this disease has steadily grown, and
1919 approximately 900 new cases of cystic fibrosis are diagnosed each
2020 year; more than 50 percent of the affected population is 18 years
2121 of age or older, and people with the disease have a variety of
2222 symptoms attributed to the more than 1,800 mutations of the CF
2323 gene; and
2424 WHEREAS, Infant blood screening to detect genetic defects
2525 is the most reliable and least costly method to identify persons
2626 likely to have cystic fibrosis; early diagnosis of the disease
2727 permits early treatment, which enhances the quality of life and
2828 longevity of patients; the treatment of CF depends on the stage
2929 of the disease and the organs involved; and
3030 WHEREAS, Clearing mucus from the lungs is an important part
3131 of the daily CF treatment regimen; other types of treatments
3232 include taking pancreatic enzymes and inhaled antibiotics; and
3333 WHEREAS, A critical component of treating patients with
3434 cystic fibrosis is access to innovative treatments, which can
3535 play a crucial role in the lives of patients with CF; and
3636 WHEREAS, There are 11 world-class treatment centers in
3737 this state which specialize in the diagnosis of cystic fibrosis
3838 and the care of persons with CF; and
3939 WHEREAS, Improving the length and quality of life for
4040 people with CF starts with awareness; now, therefore, be it
4141 RESOLVED, That the Senate of the State of Texas, 87th
4242 Legislature, hereby designate the month of May 2021 as Cystic
4343 Fibrosis Awareness Month in Texas.
4444 Buckingham, Campbell
4545 Kolkhorst, Schwertner
4646 ________________________________
4747 President of the Senate
4848 I hereby certify that the
4949 above Resolution was adopted by
5050 the Senate on May 19, 2021.
5151 ________________________________
5252 Secretary of the Senate
5353 ________________________________
5454 Member, Texas Senate
5555 ________________________________
5656 Member, Texas Senate
5757 ________________________________
5858 Member, Texas Senate
5959 ________________________________
6060 Member, Texas Senate